2017-003434-87
Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma.
Cincinnati Children's Hospital Medical Center·EU Clinical Trials Register
Study focus
- Disease/Condition
- Acute Myeloid Leukemia
Sponsor & location
- Primary sponsor
- Cincinnati Children's Hospital Medical Center
- Funder
- Jazz Pharmaceuticals
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
- Patients with Acute Promyelocytic Leukemia (APML), Down Syndrome, Fanconi Anemia, ALL and CNS leukemia (CNS status 3).
ICD-10 classifications
Myeloid leukaemiaAcute myeloblastic leukaemia [AML]Myeloid leukaemia, unspecifiedAcute myeloid leukaemia with 11q23-abnormalityAcute myelomonocytic leukaemia
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2017-003434-87
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2017-003434-87 through Pure Global AI's free database. This phase not specified trial is sponsored by Cincinnati Children's Hospital Medical Center and is currently status unknown. The study focuses on Acute Myeloid Leukemia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.